Altered Markers of Cortical γ-aminobutyric acid neuronal activity in schizophrenia role of the NARP gene

JAMA Psychiatry

Volumn 72, Issue 8, 2015, Pages 747-756

  Kimoto, Sohei ^a,b   Zaki, Mark M ^a   Holly Bazmi, H ^a   Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ARC PROTEIN; GLUTAMATE DECARBOXYLASE 67; GLUTAMIC ACID; HALOPERIDOL; MESSENGER RNA; NARP PROTEIN; OLANZAPINE; PARVALBUMIN; PLACEBO; PROTEIN; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SOMATOSTATIN; UNCLASSIFIED DRUG; ACTIVITY REGULATED CYTOSKELETAL-ASSOCIATED PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOSKELETON PROTEIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1; IMMEDIATE EARLY PROTEIN; NERVE PROTEIN; NEURONAL PENTRAXIN; PROTEIN SERINE THREONINE KINASE; SERUM-GLUCOCORTICOID REGULATED KINASE;

ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN TISSUE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; DORSOLATERAL PREFRONTAL CORTEX; DRUG EXPOSURE; FEMALE; GENE EXPRESSION; GENE FUNCTION; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMEDIATE EARLY GENE; IN SITU HYBRIDIZATION; INTERNEURON; LONG TERM EXPOSURE; MAJOR DEPRESSION; MALE; MICROARRAY ANALYSIS; MOOD DISORDER; NEUROTRANSMISSION; POLYMERASE CHAIN REACTION; PYRAMIDAL NERVE CELL; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; TREATMENT DURATION; WORKING MEMORY; BIOSYNTHESIS; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; NERVE CELL; PREFRONTAL CORTEX;

BIOLOGICAL MARKERS; BIPOLAR DISORDER; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CYTOSKELETAL PROTEINS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; IMMEDIATE-EARLY PROTEINS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; PREFRONTAL CORTEX; PROTEIN-SERINE-THREONINE KINASES; SCHIZOPHRENIA; SOMATOSTATIN;

EID: 84939809451     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.0533     Document Type: Article

References (56)

1. Herrmann CS, Munk MH, Engel AK. Cognitive functions of gamma-band activity: memory match and utilization. Trends Cogn Sci. 2004;8(8):347-355.
2. HowardMW, Rizzuto DS, Caplan JB, et al. Gamma oscillations correlate with working memory load in humans. Cereb Cortex. 2003;13(12):1369-1374.
3. Roux F, Wibral M, Mohr HM, SingerW, Uhlhaas PJ. Gamma-band activity in human prefrontal cortex codes for the number of relevant items maintained in working memory. J Neurosci. 2012;32(36):12411-12420.
4. Yamamoto J, Suh J, Takeuchi D, Tonegawa S. Successful execution of working memory linked to synchronized high-frequency gamma oscillations. Cell. 2014;157(4):845-857.
5. Cho RY, Konecky RO, Carter CS. Impairments in frontal cortical synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci U S A. 2006;103 (52):19878-19883.
6. Lesh TA, Niendam TA,MinzenbergMJ, Carter CS. Cognitive control deficits in schizophrenia: mechanisms and meaning. Neuropsychopharmacology. 2011;36(1):316-338.
7. Lewis DA, Curley AA, Glausier JR, Volk DW. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 2012;35(1):57-67.
8. Uhlhaas PJ, SingerW. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci. 2010;11(2):100-113.
9. BartosM, Vida I, Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci. 2007;8(1): 45-56.
10. Cardin JA, CarlenM, Meletis K, et al. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature. 2009;459 (7247):663-667.
11. Sohal VS, Zhang F, Yizhar O, Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature. 2009;459 (7247):698-702.
12. Lewis DA, Gonzalez-Burgos G. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology. 2008;33(1):141-165.
13. Packer AM, Yuste R. Dense, unspecific connectivity of neocortical parvalbumin-positive interneurons: a canonical microcircuit for inhibition? J Neurosci. 2011;31(37):13260-13271.
14. Gonzalez-Burgos G, Lewis DA. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull. 2008;34(5): 944-961.
15. Hajos N, Paulsen O. Network mechanisms of gamma oscillations in the CA3 region of the hippocampus. Neural Netw. 2009;22(8):1113-1119.
16. Gonzalez-Burgos G, Lewis DA. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull. 2012;38(5):950-957.
17. Hull C, Isaacson JS, Scanziani M. Postsynaptic mechanisms govern the differential excitation of cortical neurons by thalamic inputs. J Neurosci. 2009;29(28):9127-9136.
18. Korotkova T, Fuchs EC, Ponomarenko A, von Engelhardt J, Monyer H. NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron. 2010;68(3):557-569.
19. Rotaru DC, Yoshino H, Lewis DA, Ermentrout GB, Gonzalez-Burgos G. Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia. J Neurosci. 2011;31(1):142-156.
20. Fuchs EC, Zivkovic AR, Cunningham MO, et al. Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron. 2007;53(4):591-604.
21. Caputi A, Fuchs EC, Allen K, LeMagueresse C, Monyer H. Selective reduction of AMPA currents onto hippocampal interneurons impairs network oscillatory activity. PLoS One. 2012;7(6):e37318. doi:10. 1371/journal. pone. 0037318.
22. Tsui CC, Copeland NG, Gilbert DJ, Jenkins NA, Barnes C,Worley PF. NARP, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity. J Neurosci. 1996;16(8):2463-2478.
23. Chang MC, Park JM, Pelkey KA, et al. NARP regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons. Nat Neurosci. 2010;13(9):1090-1097.
24. Gu Y, Huang S, Chang MC,Worley P, Kirkwood A, Quinlan EM. Obligatory role for the immediate early gene NARP in critical period plasticity. Neuron. 2013;79(2):335-346.
25. Shepherd JD, Rumbaugh G,Wu J, et al. Arc/Arg3. 1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron. 2006;52(3):475-484.
26. Lang F, Strutz-Seebohm N, Seebohm G, Lang UE. Significance of SGK1 in the regulation of neuronal function. J Physiol. 2010;588(pt 18): 3349-3354.
27. Benson DL, Huntsman MM, Jones EG. Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys. Cereb Cortex. 1994;4(1):40-51.
28. Lau CG, Murthy VN. Activity-dependent regulation of inhibition via GAD67. J Neurosci. 2012; 32(25):8521-8531.
29. Hashimoto T, Volk DW, Eggan SM, et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 2003;23(15):6315-6326.
30. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. Decreased glutamic acid decarboxylase67messenger RNA expression in a subset of prefrontal cortical -aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry. 2000;57(3):237-245.
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
32. Volk DW, Matsubara T, Li S, et al. Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatry. 2012; 169(10):1082-1091.
33. Kimoto S, Bazmi HH, Lewis DA. Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. Am J Psychiatry. 2014; 171(9):969-978.
34. Hashimoto T, Bazmi HH, Mirnics K,Wu Q, Sampson AR, Lewis DA. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry. 2008;165(4):479-489.
35. Sibille E, Morris HM, Kota RS, Lewis DA. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol. 2011;14(6):721-734.
36. Arion D, Corradi JP, Tang S, et al. Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder [published online January 6, 2015]. Mol Psychiatry. doi:10. 1038/mp. 2014. 17.
37. Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology. 2005;30(9):1649-1661.
38. Georgiev D, Arion D, Enwright JF, et al. Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia. Am J Psychiatry. 2014;171(1):62-71.
39. Thune JJ, Uylings HB, Pakkenberg B. No deficit in total number of neurons in the prefrontal cortex in schizophrenics. J Psychiatr Res. 2001;35(1):15-21.
40. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry. 1995;52(10):805-818.
41. Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA. Somal size of prefrontal cortical pyramidal neurons in schizophrenia: differential effects across neuronal subpopulations. Biol Psychiatry. 2003;54 (2):111-120.
42. Curley AA, Arion D, Volk DW, et al. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am J Psychiatry. 2011; 168(9):921-929.
43. Hoftman GD, Volk DW, Bazmi HH, Li S, Sampson AR, Lewis DA. Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance. Schizophr Bull. 2015;41(1):180-191.
44. Bora E, Yucel M, Pantelis C. Cognitive impairment in affective psychoses: ameta-analysis. Schizophr Bull. 2010;36(1):112-125.
45. Hill SK, Reilly JL, Keefe RS, et al. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry. 2013; 170(11):1275-1284.
46. Straub RE, Lipska BK, Egan MF, et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry. 2007;12(9): 854-869.
47. Huang HS, Matevossian A, Whittle C, et al. Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci. 2007;27(42):11254-11262.
48. Bharadwaj R, Jiang Y, MaoW, et al. Conserved chromosome 2q31 conformations are associated with transcriptional regulation of GAD1 GABA synthesis enzyme and altered in prefrontal cortex of subjects with schizophrenia. J Neurosci. 2013;33 (29):11839-11851.
49. Spiegel I, Mardinly AR, Gabel HW, et al. Npas4 regulates excitatory-inhibitory balance within neural circuits through cell-type-specific gene programs. Cell. 2014;157(5):1216-1229.
50. Sanchez-Munoz I, Sanchez-Franco F, Vallejo M, et al. Activity-dependent somatostatin gene expression is regulated by cAMP-dependent protein kinase and Ca2+-calmodulin kinase pathways. J Neurosci Res. 2010;88(4):825-836.
51. Tolon RM, Sanchez Franco F, de los FrailesMT, LorenzoMJ, Cacicedo L. Effect of potassium-induced depolarization on somatostatin gene expression in cultured fetal rat cerebrocortical cells. J Neurosci. 1994;14(3, pt 1):1053-1059.
52. Fung SJ,WebsterMJ, Sivagnanasundaram S, Duncan C, ElashoffM,Weickert CS. Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am J Psychiatry. 2010;167(12): 1479-1488.
53. Fung SJ, Fillman SG,WebsterMJ, Shannon Weickert C. Schizophrenia and bipolar disorder show both common and distinct changes in cortical interneuron markers. Schizophr Res. 2014;155(1-3): 26-30.
54. Hashimoto T, Arion D, Unger T, et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry. 2008;13(2):147-161.
55. Morris HM, Hashimoto T, Lewis DA. Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cereb Cortex. 2008;18(7):1575-1587.
56. Volk DW, Chitrapu A, Edelson JR, Lewis DA. Chemokine receptors and cortical interneuron dysfunction in schizophrenia. Schizophr Res. 2014; S0920-9964(14)00600-8.